Gensight Biologics

Developer of viral vector-based gene therapies for retinal neurodegenerative diseases

placeParis, Ile De France, France calendar_todayFounded 2011 groups23 employees language gensight-biologics.com

Social engagement

Social engagement: 9.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; lead investors include Fidelity Investments, Jennison, Sphera Global Healthcare, Perceptive Advisors.

Investor typeCountShare
Venture capital947%
Private equity211%
Accelerator & incubator15%
Bank & private debt211%
Other / undisclosed526%

Recent activity

20 May 2026
Recognition
25 Mar 2026
Event
4th International Ophthalmology Conference
20 Mar 2026
Event
52nd annual meeting of the North American Neuro-Ophthalmology Society (NANOS)
Coming soon